183 related articles for article (PubMed ID: 18254324)
21. Extranodal NK/T cell lymphoma, nasal type.
Zindanci I; Demirkesen C; Kavala M; Koc M; Kocaturk E; Sudogan S; Can B
Eur J Dermatol; 2008; 18(5):604-5. PubMed ID: 18779116
[No Abstract] [Full Text] [Related]
22. MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.
Gu Y; Wu B; Zhang Y; Guo Y; Peng W
Eur Rev Med Pharmacol Sci; 2014; 18(3):404-12. PubMed ID: 24563442
[TBL] [Abstract][Full Text] [Related]
23. [Extranodal NK/T-cell lymphoma of the nasal type].
Ashurov ZM; Lutskaia TD; Mustafaev DM; Golubovskiĭ GA; Kurbanov FF
Vestn Otorinolaringol; 2008; (1):73-4. PubMed ID: 18454065
[No Abstract] [Full Text] [Related]
24. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
25. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
26. [Nasal extranodal NK/T cell lymphoma: terminologic evaluation and diagnostic problems].
Wang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 24(17):791-4. PubMed ID: 21090103
[TBL] [Abstract][Full Text] [Related]
27. [Nasal NK/T cell lymphoma with outstanding performance of ocular symptoms].
Liu L; Zhao Y; Wang J; Ma F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):786-8. PubMed ID: 23214315
[TBL] [Abstract][Full Text] [Related]
28. Nasal natural killer/T-cell lymphoma.
Lin CY; Cheng PW
Otolaryngol Head Neck Surg; 2010 Sep; 143(3):461-2. PubMed ID: 20723790
[No Abstract] [Full Text] [Related]
29. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
Lee J; Suh C; Park YH; Ko YH; Bang SM; Lee JH; Lee DH; Huh J; Oh SY; Kwon HC; Kim HJ; Lee SI; Kim JH; Park J; Oh SJ; Kim K; Jung C; Park K; Kim WS
J Clin Oncol; 2006 Feb; 24(4):612-8. PubMed ID: 16380410
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
31. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
32. Gastric involvement of extranodal NK/T-cell lymphoma, nasal type: a report of 3 cases with literature review.
Zhang YC; Sha Zhao ; Yu JB; Lei Shi ; He MX; Zhang HY; Liu WP
Int J Surg Pathol; 2008 Oct; 16(4):450-4. PubMed ID: 18492683
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
[TBL] [Abstract][Full Text] [Related]
35. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
36. Nasal extranodal natural killer T cell lymphoma: an atypical presentation.
Sharma A; Dandekar M; Deshmukh S; Dabholkar J
J Laryngol Otol; 2011 Nov; 125(11):1181-4. PubMed ID: 21733277
[TBL] [Abstract][Full Text] [Related]
37. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
[TBL] [Abstract][Full Text] [Related]
38. A case of nasal-type NK/T cell lymphoma in a patient with dermatomyositis.
Park JH; Kim YJ; Park CK; Yoo DH
Int J Rheum Dis; 2009 Jul; 12(2):166-9. PubMed ID: 20374337
[TBL] [Abstract][Full Text] [Related]
39. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
[TBL] [Abstract][Full Text] [Related]
40. [Exploration of prognostic factors in extranodal nasal-type NK/T cell lymphoma].
Han DM; Chen XQ; Bai QX
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):137. PubMed ID: 16750021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
